{"id":"https://openalex.org/W103834054","doi":null,"title":"Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.","display_name":"Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.","alternate_titles":[],"publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W103834054","mag":"103834054","pmid":"https://pubmed.ncbi.nlm.nih.gov/12856513"},"language":"en","primary_location":{"id":"pmid:12856513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12856513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of reproductive medicine","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W103834054"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014120526","display_name":"Mark G. Martens","orcid":"https://orcid.org/0000-0002-3290-6179","observed_orcids":["https://orcid.org/0000-0002-3290-6179"]},"institutions":[{"id":"https://openalex.org/I4392738079","display_name":"University of Oklahoma - Tulsa","ror":"https://ror.org/04g1a0w27","country_code":"US","type":"education","lineage":["https://openalex.org/I4392738079","https://openalex.org/I8692664"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mark G Martens","raw_affiliation_strings":["Department of Gynecology and Obstetrics, University of Oklahoma, 1145 South Utica, Suite 600, Tulsa, OK 74104-4070, USA. mark-martens@ouhsc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics, University of Oklahoma, 1145 South Utica, Suite 600, Tulsa, OK 74104-4070, USA. mark-martens@ouhsc.edu","institution_ids":["https://openalex.org/I4392738079","https://openalex.org/I8692664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014120526"],"corresponding_institution_ids":["https://openalex.org/I4392738079","https://openalex.org/I8692664"],"apc_list":null,"apc_paid":null,"fwci":3.901,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.92047239,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"48","issue":"6","first_page":"425","last_page":"434"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/postmenopausal-osteoporosis","display_name":"postmenopausal osteoporosis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/osteoporotic-fracture-prevention","display_name":"osteoporotic fracture prevention","score":0.8289999961853027},{"id":"https://openalex.org/keywords/antiresorptive-therapy","display_name":"antiresorptive therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9760000109672546},{"id":"https://openalex.org/keywords/risedronate","display_name":"risedronate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/alendronate","display_name":"alendronate","score":1.0},{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":0.9959999918937683},{"id":"https://openalex.org/keywords/calcitonin","display_name":"calcitonin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/vertebral-fractures","display_name":"vertebral fractures","score":0.9459999799728394},{"id":"https://openalex.org/keywords/non-vertebral-fractures","display_name":"non-vertebral fractures","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hip-fracture","display_name":"hip fracture","score":0.9919999837875366},{"id":"https://openalex.org/keywords/thromboembolic-risk","display_name":"thromboembolic risk","score":0.8500000238418579},{"id":"https://openalex.org/keywords/upper-gastrointestinal-diseases","display_name":"upper gastrointestinal diseases","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9636332392692566},{"id":"https://openalex.org/C2779889926","wikidata":"https://www.wikidata.org/wiki/Q425223","display_name":"Raloxifene","level":5,"score":0.9527281522750854},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.8297182321548462},{"id":"https://openalex.org/C2779809032","wikidata":"https://www.wikidata.org/wiki/Q420057","display_name":"Alendronic acid","level":4,"score":0.5678956508636475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4921554923057556},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47940966486930847},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.4791680872440338},{"id":"https://openalex.org/C2778885795","wikidata":"https://www.wikidata.org/wiki/Q240856","display_name":"Hip fracture","level":3,"score":0.46559250354766846},{"id":"https://openalex.org/C2780159708","wikidata":"https://www.wikidata.org/wiki/Q17003363","display_name":"Hormone replacement therapy (female-to-male)","level":3,"score":0.44294804334640503},{"id":"https://openalex.org/C170033053","wikidata":"https://www.wikidata.org/wiki/Q952019","display_name":"Bone remodeling","level":2,"score":0.43379852175712585},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.3785219192504883},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3743979334831238},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.11892160773277283},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.10333040356636047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09805965423583984},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002116","descriptor_name":"Calcitonin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004965","descriptor_name":"Estrogen Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017698","descriptor_name":"Postmenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020849","descriptor_name":"Raloxifene Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12856513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12856513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of reproductive medicine","raw_type":"Journal Article"},{"id":"mag:103834054","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12856513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046286698","https://openalex.org/W2145082119","https://openalex.org/W2066627369","https://openalex.org/W2014650488","https://openalex.org/W2118125113","https://openalex.org/W2128853280","https://openalex.org/W2096935087","https://openalex.org/W1512884644","https://openalex.org/W2081293147","https://openalex.org/W2029633364"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"the":[3,11,18,35,40,77,105,146,155,173,194,207],"antifracture":[4],"efficacy":[5],"of":[6,20,31,64,70,79,87,107,124,148,157,169,175,186,196,209],"pharmacologic":[7],"therapy":[8,33,52,88,191],"approved":[9],"by":[10],"U.S.":[12],"Food":[13],"and":[14,38,46,89,93,115],"Drug":[15],"Administration":[16],"for":[17,62],"treatment":[19,63],"postmenopausal":[21,71],"osteoporosis.":[22,65,215],"STUDY":[23],"DESIGN:":[24],"For":[25],"this":[26,57],"literature":[27],"review,":[28],"published":[29],"trials":[30,69,123],"antiresorptive":[32],"with":[34,73,130,164,214],"bisphosphonates":[36,201],"risedronate":[37,75],"alendronate,":[39],"selective":[41],"estrogen":[42],"receptor":[43],"modulator":[44],"raloxifene":[45,140],"calcitonin":[47],"were":[48,117,126],"reviewed;":[49],"hormone":[50],"replacement":[51],"was":[53],"not":[54,60,153],"included":[55],"as":[56],"modality":[58],"is":[59,161],"indicated":[61],"RESULTS:":[66],"In":[67,99,135],"controlled":[68,138],"women":[72,129,213],"osteoporosis,":[74],"reduced":[76,104,172],"incidence":[78,174],"clinically":[80],"evident":[81],"vertebral":[82,92,109,150,176,198],"fracture":[83,95,151,211],"after":[84,96],"6":[85],"months":[86],"radiographically":[90],"detected":[91],"nonvertebral":[94,158,187],"1":[97,112],"year.":[98,113],"similar":[100],"trials,":[101],"alendronate":[102,116,125],"also":[103,162,203],"risk":[106,147,156,168,195,208],"clinical":[108,149],"fractures":[110],"in":[111,145,154,205,212],"Risedronate":[114],"both":[118],"well":[119],"tolerated,":[120],"but":[121,152,178],"some":[122],"closed":[127],"to":[128],"recent":[131],"upper":[132],"gastrointestinal":[133],"disease.":[134],"a":[136,142,165],"large,":[137],"trial,":[139],"demonstrated":[141],"significant":[143],"reduction":[144],"fracture.":[159,188,199],"Raloxifene":[160],"associated":[163],"3-fold":[166],"increased":[167],"thromboembolism.":[170],"Calcitonin":[171],"fracture,":[177],"there":[179],"are":[180,202],"no":[181],"conclusive":[182],"data":[183],"on":[184],"prevention":[185],"CONCLUSION:":[189],"Antiresorptive":[190],"can":[192],"reduce":[193],"osteoporotic":[197],"The":[200],"effective":[204],"reducing":[206],"hip":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W103834054","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
